Gerald Willimsky
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 35
- Immunotherapy and Immune Responses 28
- Immune Cell Function and Interaction 15
- T-cell and B-cell Immunology 7
- Immune cells in cancer 4
- Oncology 29
- CAR-T cell therapy research 17
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- Thomas Blankenstein (35 shared papers)Mohamed A. Marahiel (3 shared papers)G. Fischer (1 shared paper)Holger Bang (1 shared paper)Shabnam Shalapour (3 shared papers)Tobias Klatte (1 shared paper)Peter Birner (1 shared paper)Joan Font-Burgada (1 shared paper)
- Journals
- Blood (3 papers)Gene Therapy (3 papers)Human Gene Therapy (3 papers)Frontiers in Immunology (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- GermanyUnited StatesCroatia
In The Last Decade
Gerald Willimsky
48 papers receiving 2.0k citations
Gerald Willimsky's Hit Papers
Peers
Comparison fields: 5 of 104
- Immunology 1.1k
- Oncology 901
- Biotechnology 92
- Molecular Biology 609
- Genetics 237
Countries citing papers authored by Gerald Willimsky
This map shows the geographic impact of Gerald Willimsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Willimsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Willimsky more than expected).
Fields of papers citing papers by Gerald Willimsky
This network shows the impact of papers produced by Gerald Willimsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Willimsky. The network helps show where Gerald Willimsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald Willimsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy Hit paper breakdown → | 2015 | 440 |
| 2 | 2005 | 340 | |
| 3 | 1992 | 204 | |
| 4 | 2008 | 87 | |
| 5 | 2010 | 74 | |
| 6 | 2017 | 71 | |
| 7 | 1998 | 65 | |
| 8 | Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. | 1997 | 61 |
| 9 | 2007 | 46 | |
| 10 | 2012 | 46 | |
| 11 | 1992 | 43 | |
| 12 | 2013 | 41 | |
| 13 | 2018 | 39 | |
| 14 | 2017 | 37 | |
| 15 | 2000 | 33 | |
| 16 | 2017 | 33 | |
| 17 | Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors. | 2000 | 33 |
| 18 | 2013 | 31 | |
| 19 | 2005 | 26 | |
| 20 | 2005 | 24 |
About Gerald Willimsky
Gerald Willimsky is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Biotechnology, having authored 51 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (28 papers), CAR-T cell therapy research (17 papers), Immune Cell Function and Interaction (15 papers), Cancer Immunotherapy and Biomarkers (12 papers), Virus-based gene therapy research (9 papers), T-cell and B-cell Immunology (7 papers), Immune cells in cancer (4 papers) and vaccines and immunoinformatics approaches (4 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (901 citations), Biotechnology (92 citations), Molecular Biology (609 citations) and Genetics (237 citations). Gerald Willimsky has collaborated with scholars based in Germany, United States and Croatia. Frequent co-authors include Thomas Blankenstein, Mohamed A. Marahiel, G. Fischer, Holger Bang, Shabnam Shalapour, Tobias Klatte, Peter Birner, Joan Font-Burgada, Donna E. Hansel and Debanjan Dhar. Their work appears in journals such as Blood, Gene Therapy, Human Gene Therapy, Frontiers in Immunology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.